These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1737106)
1. Mutational activation of the N-ras oncogene assessed in primary clonogenic culture of acute myeloid leukemia (AML): implications for the role of N-ras mutation in AML pathogenesis. Bashey A; Gill R; Levi S; Farr CJ; Clutterbuck R; Millar JL; Pragnell IB; Marshall CJ Blood; 1992 Feb; 79(4):981-9. PubMed ID: 1737106 [TBL] [Abstract][Full Text] [Related]
2. Persistence of an activating N-RAS oncogene mutation in clonogenic progenitor cells from an acute myeloid leukaemia patient in remission. Zaheer HA; Bagnara M; Gibson FM; Robinson G; Rutherford TR; Gordon-Smith EC Br J Haematol; 1994 Feb; 86(2):298-302. PubMed ID: 8199018 [TBL] [Abstract][Full Text] [Related]
3. N-RAS gene activation in acute myeloid leukemia: association with expression of interleukin-6. Lübbert M; Oster W; Knopf HP; McCormick F; Mertelsmann R; Herrmann F Leukemia; 1993 Dec; 7(12):1948-54. PubMed ID: 8255093 [TBL] [Abstract][Full Text] [Related]
4. Sequential acquisition of trisomy 8 and N-ras mutation in acute myeloid leukaemia demonstrated by analysis of isolated leukaemic colonies. Price CM; Marshall CJ; Bashey A Br J Haematol; 1994 Oct; 88(2):338-42. PubMed ID: 7803279 [TBL] [Abstract][Full Text] [Related]
5. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia. Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y Oncology; 1992; 49(2):114-22. PubMed ID: 1574246 [TBL] [Abstract][Full Text] [Related]
6. Ras point mutations occur in acute myeloid leukemia with illegitimate T-cell receptor delta gene rearrangement. Schmidt CA; Przybylski G; Vogel D; Ludwig WD; Oettle H; Neubauer A; Siegert W Leukemia; 1994 Jan; 8(1):102-5. PubMed ID: 8289473 [TBL] [Abstract][Full Text] [Related]
7. ras oncogene activation and occupational exposures in acute myeloid leukemia. Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344 [TBL] [Abstract][Full Text] [Related]
8. The role of methylcellulose on colony growth of human myeloid leukemic progenitors (AML-CFU). Allieri MA; Douay L; Deloux J; Smadja N; Najman A; Gorin NC Exp Hematol; 1990 Sep; 18(8):911-5. PubMed ID: 2387341 [TBL] [Abstract][Full Text] [Related]
10. Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples. Shih LY; Liang DC; Huang CF; Chang YT; Lai CL; Lin TH; Yang CP; Hung IJ; Liu HC; Jaing TH; Wang LY; Yeh TC Leukemia; 2008 Feb; 22(2):303-7. PubMed ID: 17960171 [TBL] [Abstract][Full Text] [Related]
11. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case. Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347 [TBL] [Abstract][Full Text] [Related]
13. 12th codon mutation resulting in c-N-ras activation in acute myelogenous leukemia. Needleman SW; Devine SE; Kraus MH Leukemia; 1988 Feb; 2(2):91-3. PubMed ID: 3278172 [TBL] [Abstract][Full Text] [Related]
14. N-ras mutations in myeloid leukemias. Saglio G; Serra A; Novarino A; Falda M; Gavosto F Tumori; 1989 Aug; 75(4):337-40. PubMed ID: 2683276 [TBL] [Abstract][Full Text] [Related]
15. High incidence of conservative RAS mutations in acute myeloid leukemia. Aurer I; Labar B; Nemet D; Ajduković R; Bogdanić V; Gale RP Acta Haematol; 1994; 92(3):123-5. PubMed ID: 7871950 [TBL] [Abstract][Full Text] [Related]
16. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia. Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106 [TBL] [Abstract][Full Text] [Related]
17. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation. Shen S; Passioura T; Symonds G; Dolnikov A Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045 [TBL] [Abstract][Full Text] [Related]
18. Detection of N-RAS and K-RAS in their active GTP-bound form in acute myeloid leukemia without activating RAS mutations. Ehmann F; Horn S; Garcia-Palma L; Wegner W; Fiedler W; Giehl K; Mayr GW; Jücker M Leuk Lymphoma; 2006 Jul; 47(7):1387-91. PubMed ID: 16923573 [TBL] [Abstract][Full Text] [Related]
19. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia. Venkatraj VS; Gaidano G; Auerbach AD Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673 [TBL] [Abstract][Full Text] [Related]
20. Analysis of ras gene mutations in acute myeloid leukemia by the polymerase chain reaction and oligonucleotide probes. Chin YM; Bosco JJ; Koh CL Singapore Med J; 1992 Feb; 33(1):48-50. PubMed ID: 1598607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]